Creative Biolabs-Immuno-oncology

Anti-DLK1 (clone B0Z9Q) SynExpress C-G-cF-X Synthetic CD4+ T cells (CAT#: ITS-1224-CR2116)

DatasheetDatasheet
Description
This product utilizes Synthetic CD4+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DLK1 (clone B0Z9Q). We employs the HBV (CMV-GFP-c-Fos-XbaI) vector components and the SynExpress system of the DNA methylation sites Knock-in/Negative feedback for a robust and sustained response against cancers.
Host
Human
Target
DLK1
Clone
B0Z9Q
Species Reactivity
Human
Cell Source
Synthetic CD4+ T cells
Sensor Gene
GFP
Promoter
CMV
Effector Gene
c-Fos
Insertion Sites
XbaI
Gene Modification
Knock-in
Modification Domain
DNA methylation sites
Carrier Type
HBV
Transformation Accuracy
0.93
Cell Culture
Aseptic Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.